Practice Operations · For practice managers
PRP Centrifuge Open vs Closed System Kit Cost Per Treatment
Published November 20, 2026
- Primary Cost Drivers
- Consumables & Labor
- Sterility Standard
- Closed-Barrier Transfer
- Regulatory Benchmark
- FDA 510(k) Clearance
True cost per treatment is determined by combining the disposable kit price, ancillary draw supplies, and hands-on technician processing time.
Closed systems maintain sample isolation from venipuncture to final syringe, whereas open systems expose plasma to ambient clinic air.
Devices intended for preparing autologous PRP for human re-injection require specific medical device clearance distinct from in-vitro diagnostic tubes.
Calculating the true PRP centrifuge open vs closed system kit cost per treatment requires evaluating total procedural overhead: open systems minimize per-unit hardware costs but demand extensive hands-on manual processing, whereas closed systems trade higher disposable fees for standardized sterility, rapid draw-to-injection times, and reduced biological exposure. Because technician time and clean-air preparation protocols frequently erode the initial savings of open tubes, practice procurement must look beyond basic kit pricing. This operational breakdown analyzes consumable line items, regulatory compliance demands, and workflow margins across both biologics preparation models to help practice managers optimize their regenerative clinical supplies.
Defining Open vs. Closed PRP Processing Systems
Platelet-Rich Plasma (PRP) therapy relies on centrifugation to separate autologous whole blood into distinct layers based on density, isolating platelets and plasma from red and white blood cells. The equipment and disposables used to achieve this separation fall into two operational categories: open systems and closed systems.
An open system involves drawing blood into standard collection tubes, spinning them in a general-purpose or dedicated centrifuge, and manually extracting the platelet-rich layer. During this process, the blood fraction is exposed to the ambient environment of the preparation room—typically when caps are removed and a technician uses a pipette or long spinal needle to aspirate the buffy coat or plasma layer.
A closed system is an integrated, FDA-cleared medical device kit designed to process blood without exposing the sample to room air. Blood is introduced through a sterile port, centrifuged within a sealed chamber or double-syringe apparatus, and fractionated mechanically or via closed-port aspiration. From venipuncture to final syringe transfer, the biologic material remains inside a sterile barrier.
Understanding the distinction between these two modalities is foundational for practice managers overseeing procurement of biologics and point-of-care processing equipment.
Deconstructing the True Cost Per Treatment
Practice administrators frequently encounter vendor quotes that highlight only the unit price of the disposable tube or kit. However, accurate financial modeling for a regenerative service line requires calculating the fully burdened cost per treatment.
1. Direct Consumable Costs
Closed system kits are engineered medical devices with specific regulatory clearances, proprietary separation mechanisms (such as floating shelves, thixotropic gels, or dual-chamber syringes), and bundled venipuncture accessories. Consequently, the invoice cost per kit is substantially higher than raw laboratory tubes.
Open systems often appear inexpensive on a per-unit basis because they rely on basic blood collection tubes, standard syringes, transfer needles, and separately sourced anticoagulants like ACD-A. However, practice managers must audit whether the tubes being considered are cleared for in-vivo human re-injection or merely labeled for in-vitro diagnostic (IVD) laboratory testing. Using IVD tubes for patient re-injection introduces significant regulatory and liability exposure.
2. Ancillary Supplies and Anticoagulants
A comprehensive closed kit typically packages everything required for the blood draw and processing—butterfly needles, anticoagulant, processing vessels, and transfer syringes—into a single SKU. With an open workflow, procurement teams must separately source, track, and manage expiration dates for multiple ancillary supplies, increasing inventory carrying costs and the administrative time spent reconciling stock.
3. Staff Labor and Room Turnover
In a clinical setting, staff time is a primary cost driver. Open systems require a trained technician to carefully pipette or aspirate the target layer without disturbing the red blood cell pack. This manual extraction takes longer and requires intense visual focus. If a technician inadvertently draws up too many red blood cells or loses the buffy coat, the sample quality suffers or the draw must be repeated.
Closed systems standardize the fractionation step. Many utilize a single-spin or automated dual-spin protocol where separation happens mechanically inside the device. A medical assistant can load the centrifuge, attend to other clinical duties during the spin cycle, and perform a rapid, repeatable closed transfer. Faster, predictable preparation directly increases exam room turnover.
4. Equipment Amortization and Maintenance
Some closed systems utilize proprietary centrifuges provided via capital purchase, lease, or consumable volume agreements. Open systems may run on universal swinging-bucket or fixed-angle centrifuges. While a universal centrifuge offers lower upfront capital expense, practice administrators must ensure the unit supports precise RPM/RCF calibration, soft braking (to prevent remixing of the separated layers), and routine biomedical maintenance validation.
Operational and Procurement Comparison Checklist
When reviewing vendor proposals for point-of-care blood processing devices, practice managers can use the following operational criteria to compare total cost of ownership:
- Regulatory Classification: Is the disposable kit FDA 510(k) cleared specifically for the preparation of autologous platelet-rich plasma, or are the components standard laboratory tubes not intended for human re-injection?
- Sterility Assurance: Does the sample remain isolated from ambient room air during transfer (closed), or does the workflow require uncapping tubes on a clinical countertop (open)?
- Technician Dependency: Can any trained medical assistant achieve consistent results (closed), or does the cellular yield depend heavily on the manual pipetting skill of a specific staff member (open)?
- Supply Chain Consolidation: Does the kit include anticoagulant, draw accessories, and transfer hubs under one lot number for simple charting (closed), or must staff log multiple component lot numbers per procedure (open)?
- Spin Cycle Efficiency: How many spin cycles and manual transfer steps are required, and what is the total hands-on technician time per patient?
- Waste and Redraw Rate: What is the operational protocol and cost impact if a manual extraction fails or a tube breaks during high-speed centrifugation?
Clinical Considerations for the Treating Physician
While practice administrators focus on margins, workflow efficiency, and compliance, the treating physician evaluates a PRP system based on cellular composition and clinical reproducibility. Different clinical applications—whether in orthopedics or aesthetics—often call for different PRP formulations.
From a clinical standpoint, the primary limitation of an open, manual pipetting workflow is operator-dependent variability. When a technician manually aspirates plasma near the buffy coat interface, small variations in needle depth or aspiration speed drastically alter the final concentration of platelets, leukocytes (neutrophils and monocytes), and erythrocytes.
For the physician, this variability complicates clinical protocol standardization:
- Leukocyte Control: In intra-articular orthopedic applications, clinicians often prefer leukocyte-poor PRP to minimize acute inflammatory flares triggered by neutrophils, whereas certain tendon or soft-tissue protocols may utilize leukocyte-rich preparations. Advanced closed systems are engineered to isolate or exclude the buffy coat predictably based on the device's physical geometry or sensor technology.
- Hematocrit Reduction: Red blood cells are generally undesirable in both joint injections and aesthetic dermal procedures due to iron-mediated oxidative stress and post-procedural bruising or hemosiderin staining. Closed mechanical separation provides a cleaner barrier between the erythrocyte pack and the deliverable plasma fraction.
- Dose Consistency: When a patient returns for a multi-session treatment series, the clinician wants assurance that the biologic preparation delivered in session three matches the cellular profile of session one. Closed systems minimize human error, supporting consistent clinical outcomes across multi-provider practices.
Compliance, Liability, and Risk Management
From an administrative risk perspective, infection control and regulatory alignment are paramount. Under FDA guidelines for human cells, tissues, and cellular and tissue-based products (HCT/Ps), autologous PRP prepared and administered during the same surgical procedure falls under specific regulatory exemptions, provided the devices used are cleared for that purpose.
When a practice utilizes an open system—particularly one relying on non-pyrogenic, in-vitro diagnostic blood tubes—it assumes liability for off-label device use and potential microbial contamination. Every time a tube is uncapped in a standard clinic room (which lacks an ISO-classified laminar flow hood), airborne particulates gain access to the sample. For practices serving high-expectation patient populations or operating multi-provider clinics, the compliance protection of an FDA-cleared closed system acts as an operational safeguard that outweighs the savings of raw laboratory consumables.
What This Means for Your Practice
Transitioning to or optimizing a PRP service line requires aligning your clinical goals with your operational budget. Practice managers should take the following steps before signing a consumable agreement:
- Audit Your Current Workflow: If you currently run an open or semi-open system, time your clinical staff from blood draw to final syringe readiness. Calculate the fully loaded labor cost and tally every ancillary syringe, needle, and anticoagulant vial used.
- Verify Device Clearances: Request the 510(k) clearance documentation for any PRP tube or kit under consideration to confirm it is cleared for in-vivo preparation rather than laboratory diagnostics.
- Match Kit Volume to Specialty Needs: Work with your lead physician to determine whether your schedule demands smaller-volume aesthetic kits, high-volume orthopedic systems, or a modular platform that accommodates both without overpaying for unused capacity.
- Negotiate Transparent Pricing: Look for distributor partnerships that offer straightforward per-kit pricing without restrictive, inflexible multi-year minimum volume traps.
If you are evaluating point-of-care centrifugation platforms or looking to reduce your current consumable overhead while maintaining strict clinical compliance, our team can help you compare validated options tailored to your procedural volume. Reach out through our contact page to schedule an operational review and request kit specifications for your practice.
Frequently asked questions
- What is the main difference between an open and closed PRP system?
- A closed PRP system keeps the patient's blood isolated from ambient room air throughout the draw, centrifugation, and transfer processes using sealed ports and sterile barriers. An open system requires exposing the blood sample to the room environment, typically by uncapping tubes and manually pipetting the plasma layer.
- Why do closed PRP kits have a higher upfront cost than open tubes?
- Closed PRP kits undergo rigorous FDA 510(k) clearance processes as medical devices intended for human re-injection and often include proprietary separation mechanisms and all necessary draw accessories. Open systems often use basic laboratory collection tubes that are less expensive to manufacture but require separate ancillary supplies and more staff labor.
- Are standard laboratory blood collection tubes approved for PRP injections?
- No, standard blood collection tubes (such as vacutainers labeled for in-vitro diagnostic use) are intended for laboratory testing, not for processing blood to be re-injected into a patient. Using diagnostic tubes for PRP therapy is considered off-label and carries contamination and liability risks.
- How does the choice of PRP centrifuge system affect staff workflow?
- Closed systems streamline workflow by automating or mechanically standardizing the separation of platelets, allowing medical assistants to process samples quickly and consistently. Open systems require skilled manual aspiration, which increases hands-on technician time and introduces the risk of operator error.
- Can one PRP centrifuge system work for both orthopedics and aesthetics?
- Yes, many modern closed PRP platforms offer adjustable protocols or variable kit sizes that allow clinicians to customize platelet concentration and leukocyte content. This enables a multi-specialty practice to produce leukocyte-poor PRP for joint injections or specific volumes for aesthetic microneedling using the same base centrifuge.
